{"nctId":"NCT00758485","briefTitle":"Comparing 4.0 mg.Kg-1 Sugammadex With Placebo in the Reversal of Profound Neuromuscular Blockade (P05767)","startDateStruct":{"date":"2008-10"},"conditions":["Anesthesia","Neuromuscular Blockade"],"count":140,"armGroups":[{"label":"sugammadex","type":"EXPERIMENTAL","interventionNames":["Drug: Sugammadex"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: 0.9% sodium chloride (NaCl)"]}],"interventions":[{"name":"Sugammadex","otherNames":["Org 25969","SCH 900616","MK-8616","BridionÂ®"]},{"name":"0.9% sodium chloride (NaCl)","otherNames":["Placebo"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female participants\n* American Society of Anesthesiologists (ASA) class 1, 2 or 3\n* Age \\>=18 years\n* Scheduled to undergo a surgery requiring profound NMB such as cardiovascular, gynaecologic, neurologic and thoracic surgical procedures under general anesthesia requiring neuromuscular relaxation with rocuronium for endotracheal intubation and if applicable maintenance of NMB in a position allowing neuromuscular monitoring\n* Given written informed consent\n\nExclusion Criteria:\n\n* Participants known or suspected to have neuromuscular disorders affecting NMB","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Time From Start of Administration of Investigational Medicinal Product (IMP, Sugammadex or Placebo) to Recovery of the Fourth Twitch/First Twitch (T4/T1) Ratio to 0.9","description":"Neuromuscular functioning was monitored by applying repetitive Train-Of-Four (TOF) electrical stimulations to the ulnar nerve every 15 seconds \\& assessing twitch response at the adductor pollicis muscle. T1 and T4 refer to the magnitudes (height) of the first and fourth twitches, respectively, after TOF nerve stimulation. The T4/T1 Ratio (a percentage that is expressed as a decimal of up to 1.0) indicates the extent of recovery from neuromuscular blockade (NMB), with a higher ratio indicating a greater recovery from NMB. In this study, twitch responses were recorded until the T4/T1 Ratio reached \\>=0.9, the minimum acceptable ratio that indicated complete recovery from NMB. A shorter time to recovery of the T4/T1 Ratio \\>=0.9 indicates a faster recovery from NMB.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.2","spread":null},{"groupId":"OG001","value":"89.8","spread":null}]}]}]},{"type":"SECONDARY","title":"Time From Start of Administration of IMP to Recovery of the T4/T1 Ratio to 0.7","description":"Neuromuscular functioning was monitored by applying repetitive TOF electrical stimulations to the ulnar nerve every 15 seconds \\& assessing twitch response at the adductor pollicis muscle. T1 and T4 refer to the magnitudes (height) of the first and fourth twitches, respectively, after TOF nerve stimulation. The T4/T1 Ratio (a percentage that is expressed as a decimal of up to 1.0) indicates the extent of recovery from NMB, with a higher ratio indicating a greater recovery from NMB.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.6","spread":null},{"groupId":"OG001","value":"70.1","spread":null}]}]}]},{"type":"SECONDARY","title":"Time From Start of Administration of IMP to Recovery of the T4/T1 Ratio to 0.8","description":"Neuromuscular functioning was monitored by applying repetitive TOF electrical stimulations to the ulnar nerve every 15 seconds \\& assessing twitch response at the adductor pollicis muscle. T1 and T4 refer to the magnitudes (height) of the first and fourth twitches, respectively, after TOF nerve stimulation. The T4/T1 Ratio (a percentage that is expressed as a decimal of up to 1.0) indicates the extent of recovery from NMB, with a higher ratio indicating a greater recovery from NMB.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.8","spread":null},{"groupId":"OG001","value":"78.8","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":69},"commonTop":["Procedural Pain","Wound Complication","Nausea","Headache","Flatulence"]}}}